Ferring Pharmaceuticals now sells HGH Zomacton 5mg 15IU Ferring. This growth hormone is manufactured in Germany and now selling around the world. We have obtained it here in the Mexican market and can distribute it to you in the USA, Canada or abroad. The only countries we cannot ship to are Germany, Italy, Australia, New Zealand or Norway.
HGH Zomacton 5mg 15IU Ferring is a bit lower priced than the Pfizer Genotropin because this brand has only been approved in the USA since 2015. They are establishing the brand and have a lower cost to acquire more customers. We have conducted IGF-1 blood panels on ourselves before using Zomacton and then after. HGH Zomacton 5mg 15IU Ferring more than doubled our IGF-1 scores. We like this brand and its affordable cost.
You will need a 3ml intramuscualr syringe to get all the bacteriostatic water out of the liquid vial. There will be 2ml of bacteriostatic water there. Then inject that into the vial with the powder real slow. Then slowly move the vial around to mix the contents. Takes about 5 minutes.Then it is ready for use. Since there are 2ml of liquid and 15IU of powder we do the math of 200 units of water divided by 15 units of hgh. 200 / 15 = 13.33333. So then when you use an insulin needle to take out the mixed contents every 13 tics on the syringe is 1IU. So fill the insulin syringe up to 53 for 4IU. That will be slightly past halfway full of a 1ml insulin syringe. Then inject in your stomach fat or shoulder first thing in the morning before food.
HGH Zomacton 5mg 15IU Ferring
[somatropin (rDNA origin)] for Injection, a polypeptide of recombinant DNA origin, has 191 amino acid residues and a molecular weight of about 22,124 daltons. It has an amino acid sequence identical to that of human growth hormone of pituitary origin. ZOMACTON is a strain of Escherichia coli modified by insertion of the human growth hormone gene. ZOMACTON is a sterile, white, lyophilized powder, intended for subcutaneous administration, after reconstitution with the accompanying diluent. ZOMACTON 5 mg vial contains recombinant somatropin 5 mg and mannitol 30 mg. The 5 mg vial is supplied in a combination package with an accompanying 5 mL vial of diluting solution. The diluent contains bacteriostatic 0.9% sodium chloride injection, USP, (normal saline), 0.9% benzyl alcohol as a preservative, and water for injection.
Clinical trials have demonstrated that HGH Zomacton 5mg 15IU Ferring is equivalent in its therapeutic effectiveness and in its pharmacokinetic profile to those of human growth hormone of pituitary origin (somatropin). ZOMACTON stimulates linear growth in children who lack adequate levels of endogenous growth hormone. Treatment of growth hormone-deficient children with ZOMACTON produces increased growth rates and IGF-1 (Insulin-Like Growth Factor-1) concentrations that are similar to those seen after therapy with human growth hormone of pituitary origin. Both ZOMACTON and somatropin have also been shown to have other actions including: A.
1. Skeletal Growth. HGH Zomacton 5mg 15IU Ferring stimulates skeletal growth in patients with growth hormone deficiency. The measurable increase in body length after administration of ZOMACTON results from its effect on the epiphyseal growth plates of long bones. Concentration of IGF-1, which may play a role in skeletal growth, are low in the serum of growth hormone-deficient children but increase during treatment with ZOMACTON. Mean serum alkaline phosphatase concentrations are increased.
2. Cell Growth. It has been shown that there are fewer skeletal muscle cells in short statured children who lack endogenous growth hormone as compared with normal children. Treatment with somatropin results in an increase in both the number and size of muscle cells.
3. Organ Growth. Somatropin influences the size of internal organs and it also increases red cell mass. B. Protein Metabolism Linear growth is facilitated, in part, by increased cellular protein synthesis. Nitrogen retention, as demonstrated by decreased urinary nitrogen excretion and serum urea nitrogen, results from treatment with somatropin. C. Carbohydrate Metabolism Children with hypopituitarism sometimes experience fasting hypoglycemia that is improved by treatment with somatropin. Large doses of somatropin may impair glucose tolerance. D. Lipid Metabolism Administration of somatropin to growth hormone-deficient patients mobilizes lipid, reduces body fat stores.